Integrated DNA Technologies
For more than 35 years, Integrated DNA Technologies have been enabling genomics laboratories with an oligonucleotide manufacturing process unlike anyone else in the industry, with the most advanced synthesis, modification, purification and quality control capabilities available.
Latest Integrated DNA Technologies Content
Product News
Integrated DNA Technologies Bolsters Comprehensive Genomic Profiling Solutions With Launch of New Archer™ HRD Technology for Cancer Research
Archer CGP research assays now enable homologous recombination deficiency (HRD) assessment for identification of key biomarkers critical for cancer research.
Product News
Integrated DNA Technologies Announces New Licensing Agreement With SeQure Dx To Advance CRISPR-Based Therapeutics
Strategic activation unites best-in-class technology with end-to-end development solutions to optimize therapeutic development process.
Product News
Integrated DNA Technologies Announces New Primers and Probe Set To Identify H5N1 Avian Influenza
PCR/qPCR solution will support surveillance and monitoring of the current H5N1 strain of bird flu in response to multi-state outbreak in U.S. dairy cows.
Product News
Integrated DNA Technologies Opens New Therapeutic Manufacturing Facility
Expanded footprint, new capabilities mark IDT’s entrance into CRISPR therapeutics space.
Product News
Integrated DNA Technologies and Aldevron® Activate Strategic Partnership
Under the new agreement, Integrated DNA Technologies (IDT) will sell Aldevron cGMP-manufactured CRISPR nucleases to enable customers to rapidly transition from discovery to clinic.
Article
The Potential for Groundbreaking Discoveries With CRISPR Screening
In this article, we consider various platforms to modulate gene expression and the potential of CRISPR-Cas systems to understand and treat diseases, from cancers and congenital disorders to overcoming the growing prevalence of antimicrobial resistance.
News
Machine Learning Could Boost Liquid Biopsy Cancer Diagnoses
Short pieces of DNA floating in the bloodstream of cancer patients can help doctors diagnose specific types of cancer and choose the most effective treatment.
Product News
Integrated DNA Technologies Launches New Respiratory Virus Panel
New ready-to-ship xGen™ NGS solution will enable researchers to combat challenging diseases of today and prepare for the next pathogen of tomorrow.
Article
Where the Wild Things Are: Zoonotic Research Requires a Focus on the Wild
In this opinion piece, Han Wei and Brittany Niccum outline the need for vigilance about what’s happening in the natural world and how collaboration can help to identify and prepare for the next significant zoonotic threat.
Article
Next-Generation Sequencing in Precision Oncology: Detecting Minimal Residual Disease
The development of next-generation sequencing (NGS) has made the sequencing of patient tissues or tumors a realistic option and has allowed for the rapid development of personalized cancer treatments. This article explores how NGS is being used in precision oncology to detect minimal residual disease.
Advertisement
